Health Condition 1: F20- Schizophrenia
Conditions
Interventions
Intervention1: HOMOEOPATHIC MEDICINES IN LM POTENCY: Suitable LM potency will be selected on according to the principles of homoeopathy adviced by Hahnemann. Potencies will be administered starting fr
Sponsors
DR VENMANI KANAL S
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who fulfill the diagnostic criteria for schizophrenia with positive symptoms in DSM-5. 2. Ages from 19 to 65.
Exclusion criteria
Exclusion criteria: 1. Patients with more negative symptoms. 2. Patients with substance induced psychotic illness. 3. Patients with serious systemic illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To find out the effectiveness of homoeopathicmanagement with LM potency in positive symptoms of schizophrenia.Timepoint: outcome data will be obtained once in a month by SAPS scale and once in 3 months by PANSS. Patientâ??s quality of life is measured by World Health Organization quality of life (WHO QOL) at baseline and later at 3 months interval of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To find out the changes in the quality of life of schizophrenia patients after individualized homoeopathic LM potency.. 2.To find out the group of homoeopathic medicines that are more useful in the management of schizophrenia. Timepoint: 1 YEAR FOLLOW UP | — |
Countries
India
Contacts
Public ContactDR JAYASHREE JANAGAM
National homoeopathic research institute in mental health
Outcome results
None listed